PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
Jing Yuan(Shandong Provincial QianFoShan Hospital), Shubha Bagrodia(Scripps Research Institute)
Cited by 160
Related Papers
Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design
|MedChemComm|2010|73
Changing Brain Metabolism Patterns in Patients With ANMDARE
|Clinical Nuclear Medicine|2016|61
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
|Journal of Medicinal Chemistry|2020|40